SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 28.40 |
Enterprise Value ($M) | 19.95 |
Book Value ($M) | 8.50 |
Book Value / Share | 0.90 |
Price / Book | 3.34 |
NCAV ($M) | 8.26 |
NCAV / Share | 0.88 |
Price / NCAV | 3.44 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.81 |
Return on Assets (ROA) | -1.50 |
Return on Equity (ROE) | -2.67 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.17 |
Current Ratio | 4.17 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.87 |
Assets | 11.11 |
Liabilities | 2.61 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.99 | -69.59 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
270,595 | 733,336 | 36.90 | |
260,993 | 1,173,836 | 22.23 | |
365,379 | 945,995 | 38.62 | |
230,980 | 589,518 | 39.18 | |
(click for more detail) |
Similar Companies | |
---|---|
GLTO – Galecto, Inc. | GNLX – Genelux Corporation |
GNPX – Genprex, Inc. | GRCE – Grace Therapeutics, Inc. |
GTBP – GT Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io